Cerus Corporation (CERS) Stock Overview
NASDAQ · Healthcare · Medical Devices
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Cerus Corporation
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to…
Source: Yahoo Finance
Sector & Industry
Cerus Corporation operates in the Healthcare sector, within the Medical Devices industry group. It is listed on the NASDAQ exchange.
Cerus Corporation at a Glance
| Company | Cerus Corporation |
| Ticker | CERS |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $2.59 |
| Market cap | $521.95M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.03 |
| 52-week high | $3.47 |
| 52-week low | $1.17 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.80 |
| Return on equity (ROE) | -10.77% |
| Debt-to-equity | 108.60% |
| Average volume | 2.56M |
| Shares outstanding | 201.52M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 261 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Cerus Corporation's current P/E ratio?
- Cerus Corporation (CERS) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Cerus Corporation's market capitalisation?
- Cerus Corporation's market cap is $521.95M based on our latest snapshot. See how it ranks by market cap →
- What is CERS's 52-week range?
- Over the past 52 weeks, CERS has traded between $1.17 and $3.47. What does the 52-week range mean? →
- How volatile is Cerus Corporation compared to the market?
- Cerus Corporation has a beta of 1.80, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Cerus Corporation pay a dividend?
- Cerus Corporation does not currently pay a dividend according to our latest data.
- What exchange is CERS listed on?
- CERS is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Cerus Corporation in?
- Cerus Corporation is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →